Marissa Brittenham - SGRY / Surgery Partners, Inc. - Insider Trade Report

Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Marissa Brittenham in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Marissa Brittenham in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2026-03-13	3,657	12.5400	3,657	12.5400	45,859	14	11.4900	-3,839	-8.37
2026-03-06	8,785	13.7000	8,785	13.7000	120,354
2025-03-10	3,156	24.0900	3,156	24.0900	76,028
2025-02-07	14,700	25.6100	14,700	25.6100	376,467
2024-03-04	1,284	30.1700	1,284	30.1700	38,738
2024-02-02	1,637	31.8900	1,637	31.8900	52,204
2023-02-02	1,320	35.9000	1,320	35.9000	47,388

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Transaction History